Reassessing the Time Course for Radiation-Induced Cardiac Mortality in Patients With Breast Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 97, Issue 2, 2017, Pages 303-305

  Marks, Lawrence B ^a   Zagar, Timothy M ^a   Kaidar Person, Orit ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HEART DISEASE; HEART PERFUSION; HUMAN; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TARGET TISSUE; BREAST TUMOR; CONFORMAL RADIOTHERAPY; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; FEMALE; INTERNATIONAL COOPERATION; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIATION INJURY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; UTILIZATION;

BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEART DISEASES; HUMANS; INTERNATIONALITY; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85009113184     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.10.036     Document Type: Article

References (14)

1. 1 Darby, S.C., Ewertz, M., McGale, P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368 (2013), 987–998.
2. 2 van Nimwegen, F.A., Schaapveld, M., Cutter, D.J., et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34 (2016), 235–243.
3. 3 Gharzai, L., Verma, V., Denniston, K.A., et al. Radiation therapy and cardiac death in long-term survivors of esophageal cancer: An analysis of the Surveillance, Epidemiology, and End Result database. PLoS One, 11, 2016, e0158916.
4. 4 Hojris, I., Overgaard, M., Christensen, J.J., et al. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354 (1999), 1425–1430.
5. 5 Cuzick, J., Stewart, H., Rutqvist, L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994), 447–453.
6. 6 Cuzick, J., Stewart, H., Peto, R., et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 71 (1987), 7–14.
7. 7 Cuzick, J., Stewart, H.J., Peto, R., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Recent Results Cancer Res 111 (1988), 108–129.
8. 8 Marks, L.B., Yu, X., Prosnitz, R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005), 214–223.
9. 9 Gyenes, G., Fornander, T., Carlens, P., et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study. Int J Radiat Oncol Biol Phys 36 (1996), 899–905.
10. 10 Zellars, R., Bravo, P.E., Tryggestad, E., et al. SPECT analysis of cardiac perfusion changes after whole-breast/chest wall radiation therapy with or without active breathing coordinator: Results of a randomized phase 3 trial. Int J Radiat Oncol Biol Phys 88 (2014), 778–785.
11. 11 Hancock, S.L., Tucker, M.A., Hoppe, R.T., Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993), 1949–1955.
12. 12 Bradley, J.D., Paulus, R., Komaki, R., et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): A randomised, two-by-two factorial phase 3 study. Lancet Oncol 16 (2015), 187–199.
13. 13 Overgaard, M., Christensen, J.J., Johansen, H., et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 19 (1990), 1121–1124.
14. 14 Chung, E., Corbett, J.R., Moran, J.M., et al. Is there a dose-response relationship for heart disease with low-dose radiation therapy?. Int J Radiat Oncol Biol Phys 85 (2013), 959–964.